Total | FF | MF | FP | |||||||
---|---|---|---|---|---|---|---|---|---|---|
N | Mean (SD) | N | Mean (SD) | N | β | 95% CI | N | β | 95% CI | |
Symptom-free days | 417 | 14.58 (8.42) | 208 | 15.45 (8.29) | 102 | −1.22 | −3.16 to 0.72 | 107 | −1.95 | −3.87 to −0.03 |
Country sub-groups | ||||||||||
France | 152 | 14.45 (8.74) | 75 | 16.15 (8.43) | 36 | −3.03 | −6.37 to 0.32 | 41 | −2.77 | −6.03 to 0.49 |
Germany | 165 | 16.19 (7.70) | 83 | 16.45 (7.74) | 42 | −0.81 | −3.68 to 2.07 | 40 | −0.59 | −3.50 to 2.33 |
Spain | 100 | 12.12 (8.51) | 50 | 12.74 (8.51) | 24 | 1.48 | −2.56 to 5.53 | 26 | −0.98 | −4.99 to 3.03 |
Severity sub-groups | ||||||||||
Mild intermittent | 50 | 18.72 (8.34) | 26 | 20.23 (7.69) | 9 | −1.77 | −9.12 to 5.58 | 15 | −2.30 | −8.68 to 4.08 |
Moderate/severe intermittent | 138 | 15.21 (7.57) | 74 | 15.05 (7.49) | 38 | 1.44 | −1.57 to 4.46 | 26 | −1.76 | −5.23 to 1.70 |
Moderate/severe persistent | 229 | 13.30 (8.62) | 108 | 14.56 (8.62) | 55 | −2.50 | −5.29 to 0.28 | 66 | −1.95 | −4.58 to 0.69 |